Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition - Roche Holding ( OTC:RHHBY )
On Wednesday, Roche Holdings AG RHHBY released its third-quarter sales report. Sales increased 9% year over year to 15.14 billion Swiss francs ( ~$17.5 billion ) . The company's pharmaceuticals division reported sales of 11.62 billion Swiss francs.
| Ticker |
Sentiment |
Impact |
|
VKTX
|
Neutral
|
16 %
|
|
AZN
|
Neutral
|
16 %
|
|
CTLT
|
Neutral
|
32 %
|
|
NVO
|
Neutral
|
16 %
|
|
GPCR
|
Neutral
|
16 %
|
|
AMGN
|
Neutral
|
16 %
|
|
PFE
|
Neutral
|
16 %
|
